Summary of the action
HSBC has moved Procter & Gamble's rating down to Hold from Buy and cut its price target from $182 to $149. The brokerage said the company's ongoing reinvestment in marketing and innovation has so far failed to translate into meaningful volume growth or margin recovery, even as spending has continued.
Quarterly results and momentum
P&G's fiscal fourth-quarter figures illustrated the slowdown that prompted the downgrade. Organic sales were flat year-on-year after registering 3% growth in the prior quarter. Reported revenue of $21.2 billion broadly met expectations, and adjusted earnings per share of $1.43 marginally exceeded consensus. However, adjusted operating income fell short of estimates, as higher selling and marketing expenses offset productivity improvements.
HSBC's interpretation
The brokerage described the flat organic sales as a reversal of the earlier volume recovery that underpinned its former bullish stance. While P&G management attributed some of the weaker performance to retailer inventory reductions and the timing of Amazon Prime Day, HSBC concluded that a return to steady growth is taking longer than it had anticipated.
Company outlook and financial plans
For fiscal 2027, P&G is forecasting reported and organic sales growth of 1% to 3%. Core earnings per share are expected to be flat to up 3% - assumptions the company says reflect elevated raw material, energy and transportation costs, as well as higher interest expense and foreign exchange headwinds. P&G also plans to return about $10 billion to shareholders via dividends and to repurchase roughly $5 billion of shares during the year.
Valuation and forward view
HSBC reduced its fiscal 2027-2029 earnings estimates and lowered the valuation multiples it applies to P&G. The brokerage noted that shares are trading close to their historical averages, which limits potential for multiple expansion until the company's reinvestment strategy results in sustained volume growth and margin improvement.
Bottom line
HSBC's downgrade and revised targets reflect its view that P&G's renewed investment efforts have not yet produced the higher volumes and margin recovery necessary to justify a more optimistic rating or valuation. P&G's modest sales and earnings guidance for fiscal 2027, alongside planned shareholder returns, frame the near-term financial picture as one of gradual progress rather than a quick turnaround.